Entering text into the input field will update the search result below

Trevena, Inc. (TRVN) CEO Carrie Bourdow on Q1 2020 Results - Earnings Call Transcript

May 07, 2020 12:47 PM ETTrevena, Inc. (TRVN)
SA Transcripts profile picture
SA Transcripts

Trevena, Inc. (NASDAQ:TRVN) Q1 2020 Earnings Conference Call May 7, 2020 8:00 AM ET

Company Participants

Robert Yoder - Senior Vice President and Chief Business Officer

Carrie Bourdow - President and Chief Executive Officer

Mark Demitrack - Senior Vice President and Chief Medical Officer

Barry Shin - Senior Vice President and Chief Financial Officer

Conference Call Participants

Jason Butler - JMP Securities

Douglas Tsao - H.C. Wainwright & Co., LLC


Ladies and gentlemen, thank you for standing by, and welcome to the Trevena, Inc. First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Mr. Bob Yoder, Chief Business Officer. Thank you. Please go ahead, sir.

Robert Yoder

Good morning, and welcome, everyone. Thank you for joining us on this morning's call. With me today are Carrie Bourdow, our President and CEO; Mark Demitrack, our Chief Medical Officer; and Barry Shin, our Chief Financial Officer.

Before we begin, we wish to inform participants that we will be making forward-looking statements on this call, which are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995.

You are cautioned that forward-looking statements involve risks and uncertainties, including risks detailed from time-to-time in the Company's periodic reports filed with the Securities and Exchange Commission, and we undertake no obligation to update these statements beyond today.

During today's call, Carrie will give some opening remarks on our progress of oliceridine and I'll provide an overview of our commercial launch strategy. Mark will then provide some additional details on our ongoing pipeline activities and Barry will review our

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.